1![Clarification on assertions made about Valeant’s business Allergan has based most of their analysis on IMS’s U.S. prescription data, including products that we do not own, and missing many products, geographies, and Clarification on assertions made about Valeant’s business Allergan has based most of their analysis on IMS’s U.S. prescription data, including products that we do not own, and missing many products, geographies, and](https://www.pdfsearch.io/img/68b193c6057d8e9f28f9dd8df5d66b47.jpg) | Add to Reading ListSource URL: www.valeant.comLanguage: English - Date: 2014-06-23 17:17:25
|
---|
2![Microsoft Word - Ophthalmic Anti-Inflammatories Dec 09.doc Microsoft Word - Ophthalmic Anti-Inflammatories Dec 09.doc](https://www.pdfsearch.io/img/a30722e2cda7737735176560f141d69c.jpg) | Add to Reading ListSource URL: www.oregon.govLanguage: English - Date: 2014-07-15 14:00:37
|
---|
3![Approval of Generic Ophthalmic Suspensions/Emulsions: Current Status and Challenges Uday Kompella, PhD Professor of Pharmaceutical Sciences, Ophthalmology, and Bioengineering Approval of Generic Ophthalmic Suspensions/Emulsions: Current Status and Challenges Uday Kompella, PhD Professor of Pharmaceutical Sciences, Ophthalmology, and Bioengineering](https://www.pdfsearch.io/img/dde74974468ac70c7b14f8cc19ba0f58.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
4![NDA[removed]S-063 Page 3 FML® (fluorometholone ophthalmic suspension, USP) 0.1% sterile DESCRIPTION NDA[removed]S-063 Page 3 FML® (fluorometholone ophthalmic suspension, USP) 0.1% sterile DESCRIPTION](https://www.pdfsearch.io/img/d62bbae5cfee528b0fb8293a175ec688.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2013-02-14 16:20:43
|
---|
5![NDA[removed]S-025 Page 3 FML FORTE® (fluorometholone ophthalmic suspension, USP) 0.25% NDA[removed]S-025 Page 3 FML FORTE® (fluorometholone ophthalmic suspension, USP) 0.25%](https://www.pdfsearch.io/img/bf4c133895f1cbc93523c57f05d8f1a9.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2013-02-14 16:20:43
|
---|
6![N22-212S011 Difluprednate Clinical BPCA N22-212S011 Difluprednate Clinical BPCA](https://www.pdfsearch.io/img/8fdf66042c92947d5b0c413d484c0ae0.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
7![(fluorometholone acetate ophthalmic suspension) Sterile (fluorometholone acetate ophthalmic suspension) Sterile](https://www.pdfsearch.io/img/7831fd648870eaa3bf2c22e9329b97cf.jpg) | Add to Reading ListSource URL: ecatalog.alcon.comLanguage: English - Date: 2011-06-29 17:34:38
|
---|